| pubmed-article:2150444 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2150444 | lifeskim:mentions | umls-concept:C0009170 | lld:lifeskim |
| pubmed-article:2150444 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:2150444 | lifeskim:mentions | umls-concept:C0332157 | lld:lifeskim |
| pubmed-article:2150444 | lifeskim:mentions | umls-concept:C0442805 | lld:lifeskim |
| pubmed-article:2150444 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:2150444 | lifeskim:mentions | umls-concept:C0023688 | lld:lifeskim |
| pubmed-article:2150444 | lifeskim:mentions | umls-concept:C1523689 | lld:lifeskim |
| pubmed-article:2150444 | lifeskim:mentions | umls-concept:C1510827 | lld:lifeskim |
| pubmed-article:2150444 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:2150444 | pubmed:dateCreated | 1991-4-26 | lld:pubmed |
| pubmed-article:2150444 | pubmed:abstractText | Prenatal exposure to cocaine can result in abnormal neurobehavioral development. This study found an increase in D2 dopamine receptor binding, associated with an increase in ligand affinity, in striatum of weanling rats exposed prenatally to cocaine. There were no changes in D2 receptor binding in nucleus accumbens nor D1 receptor binding in either striatum or nucleus accumbens. Alterations in D2 dopamine receptors may be associated with neurobehavioral alterations following prenatal cocaine exposure. | lld:pubmed |
| pubmed-article:2150444 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2150444 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2150444 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2150444 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2150444 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2150444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2150444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2150444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2150444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2150444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2150444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2150444 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2150444 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:2150444 | pubmed:issn | 0091-3057 | lld:pubmed |
| pubmed-article:2150444 | pubmed:author | pubmed-author:AhnS MSM | lld:pubmed |
| pubmed-article:2150444 | pubmed:author | pubmed-author:SpearL PLP | lld:pubmed |
| pubmed-article:2150444 | pubmed:author | pubmed-author:ScalzoF MFM | lld:pubmed |
| pubmed-article:2150444 | pubmed:author | pubmed-author:FrambesN ANA | lld:pubmed |
| pubmed-article:2150444 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2150444 | pubmed:volume | 37 | lld:pubmed |
| pubmed-article:2150444 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2150444 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2150444 | pubmed:pagination | 371-3 | lld:pubmed |
| pubmed-article:2150444 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:2150444 | pubmed:meshHeading | pubmed-meshheading:2150444-... | lld:pubmed |
| pubmed-article:2150444 | pubmed:meshHeading | pubmed-meshheading:2150444-... | lld:pubmed |
| pubmed-article:2150444 | pubmed:meshHeading | pubmed-meshheading:2150444-... | lld:pubmed |
| pubmed-article:2150444 | pubmed:meshHeading | pubmed-meshheading:2150444-... | lld:pubmed |
| pubmed-article:2150444 | pubmed:meshHeading | pubmed-meshheading:2150444-... | lld:pubmed |
| pubmed-article:2150444 | pubmed:meshHeading | pubmed-meshheading:2150444-... | lld:pubmed |
| pubmed-article:2150444 | pubmed:meshHeading | pubmed-meshheading:2150444-... | lld:pubmed |
| pubmed-article:2150444 | pubmed:meshHeading | pubmed-meshheading:2150444-... | lld:pubmed |
| pubmed-article:2150444 | pubmed:meshHeading | pubmed-meshheading:2150444-... | lld:pubmed |
| pubmed-article:2150444 | pubmed:meshHeading | pubmed-meshheading:2150444-... | lld:pubmed |
| pubmed-article:2150444 | pubmed:meshHeading | pubmed-meshheading:2150444-... | lld:pubmed |
| pubmed-article:2150444 | pubmed:meshHeading | pubmed-meshheading:2150444-... | lld:pubmed |
| pubmed-article:2150444 | pubmed:meshHeading | pubmed-meshheading:2150444-... | lld:pubmed |
| pubmed-article:2150444 | pubmed:meshHeading | pubmed-meshheading:2150444-... | lld:pubmed |
| pubmed-article:2150444 | pubmed:meshHeading | pubmed-meshheading:2150444-... | lld:pubmed |
| pubmed-article:2150444 | pubmed:meshHeading | pubmed-meshheading:2150444-... | lld:pubmed |
| pubmed-article:2150444 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2150444 | pubmed:articleTitle | Weanling rats exposed prenatally to cocaine exhibit an increase in striatal D2 dopamine binding associated with an increase in ligand affinity. | lld:pubmed |
| pubmed-article:2150444 | pubmed:affiliation | Division of Reproductive and Developmental Toxicology, National Center for Toxicological Research, Jefferson, AR 72079. | lld:pubmed |
| pubmed-article:2150444 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2150444 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:2150444 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2150444 | lld:pubmed |
